Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIA-662 in Hypertriglyceridemia and Mixed Hyperlipidemia
NCT02008084Phase 2Completed
- Sponsor
- Cortria
- Start
- Dec 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 1-methylnicotinamide in hypertriglyceridemia, mixed hyperlipidemia, sponsored by Cortria. Started Dec 2013; status: completed.
02
Drugs
1-methylnicotinamide
03
Conditions
hypertriglyceridemiamixed hyperlipidemia
Beyond the preview
Go deeper on NCT02008084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008084.